New Journey Health Technology Group Co.,LTD

Equities

002219

CNE1000009R5

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-16 pm EDT 5-day change 1st Jan Change
2.44 CNY +1.67% Intraday chart for New Journey Health Technology Group Co.,LTD -2.01% -19.47%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
New Journey Health Technology Group Co.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
New Journey Health Technology Group Co.,LTD Reports Earnings Results for the Full Year Ended December 31, 2023 CI
New Journey Health Technology Group Co.,LTD Approves Election of Xue Ping as A Non-Independent Director CI
New Journey Health Technology Group Co.,LTD announced that it has received CNY 685.815872 million in funding from Beijing New Journey Health Industry Group Co., Ltd. CI
New Journey Health Technology Group Co.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
New Journey Health Technology Group Co.,LTD(XSEC:002219) added to S&P Global BMI Index CI
New Journey Health Technology Group Co.,LTD Approves Board Appointments CI
New Journey Health Technology Group Co.,LTD Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Hengkang Medical’s Controlling Shareholder Boosts Stake to 29% After 686 Million Yuan Deal MT
New Journey Health Technology Group Co.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
New Journey Health Technology Group Co.,LTD Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Hengkang Medical to Build 350 Million Yuan TCM Factory MT
New Journey Health Technology Group Co.,LTD agreed to acquire remaining 99.9% stake in Lankao Oriental Hospital Co., Ltd. from Jingfu Huayue Asset Management Center (Limited Partnership), a fund managed by New Journey Health Technology Group Co.,LTD for CNY 35.8 million CI
New Journey Health Technology Group Co.,LTD agreed to acquire 81.42% stake in Siyang County People's Hospital Co., Ltd. from Jingfu Huacai Asset Management Center (Limited Partnership), a fund managed by Capital Fortune Asset Management Limited for CNY 592.5 million CI
Jingfu Huayue Asset Management Center (Limited Partnership) managed by Capital Fortune Asset Management Limited agreed to acquire Lankao First Hospital Co., Ltd. from New Journey Health Technology Group Co.,LTD for CNY 329.219 million. CI
New Journey Health Technology Group Co., Ltd. agreed to acquire 99.9% stake in Lankao Guyang Hospital Co., Ltd. () from Jingfu Huayue Asset Management Center (Limited Partnership) managed by Capital Fortune Asset Management Limited for CNY 26 million. CI
Hengkang Medical’s Controlling Shareholder Raises Stake to 30% After 686 Million Yuan Deal; Shares Rise 3% MT
Hengkang Medical Group Co., Ltd. announced that it expects to receive CNY 685.815872 million in funding from Beijing New Journey Health Industry Group Co., Ltd. CI
Hengkang Medical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Hengkang Medical Group Co., Ltd. has Changed its Name to New Journey Health Technology Group Co., Ltd CI
Hengkang Medical Group Co., Ltd. Announces Executive Appointments CI
Hengkang Medical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Shenzhen Bourse to Revoke Delisting Risk Warning on Hengkang Medical Group MT
Hengkang Medical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Hengkang Medical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Chart New Journey Health Technology Group Co.,LTD
More charts
New Journey Health Technology Group Co Ltd, formerly Hengkang Medical Group Co Ltd, is a China-based company mainly engaged in the provision of medical services. The Company is mainly engaged in two businesses. The medical service business mainly provides medical services in general hospitals and specialized hospitals. The pharmaceutical manufacturing business is mainly engaged in the research and development, production and sales of pharmaceuticals. The Company mainly conducts its businesses in the domestic market.
More about the company
  1. Stock Market
  2. Equities
  3. 002219 Stock
  4. News New Journey Health Technology Group Co.,LTD
  5. Shenzhen Bourse to Revoke Delisting Risk Warning on Hengkang Medical Group
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW